EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Host-interferon-stimulated gene response to virus-host recombinant variants of hepatitis E virus and enhanced viral replication

Olivia Paronetto, Claire Allioux, Margot Zahm, Anne Alicia Gonzalez, Nicolas Jeanne iD, Adeline Chaubet, Nived Collercandy iD, Florence Abravanel, Émeline Lhuillier, Sabine Chapuy-Regaud, Jacques Izopet iD, Sébastien Lhomme iD

Microbiology Spectrum · 2026

DOI: 10.1128/spectrum.00600-26 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, 2026. Verfasst von Olivia Paronetto und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institut Toulousain des Maladies Infectieuses et Inflammatoires (Infinity), UMR 5051 (CNRS), UMR 1291 (INSERM), Université́ de Toulouse, Toulouse, Fr…. Hauptthemen laut MEDLINE: Hepatitis E virus, Virus Replication, Hepatitis E, Interferons. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agence Nationale de Recherches sur le Sida et les Hépatites Virales (ANRS).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The hepatitis E virus (HEV) is a leading cause of acute hepatitis worldwide. HEV infection can become chronic in immunocompromised individuals, in whom virus–host recombinant variants (VHRVs) can be detected. These variants often harbor host-derived insertions in the polyproline-rich region (PPR), and most display enhanced replication in vitro . However, the mechanisms underlying this replicative advantage remain unclear. It is likely that genes of the infected cells are differentially expressed according to the replicative capacity of the strain. The host factors involved in the improvement of the replicative capacity of these VHRVs are yet to be identified. In this study, we analyzed the host transcriptional response to seven VHRVs in HepG2/C3A cells using bulk RNA sequencing at 48 h and 168 h post-infection. Five VHRVs (RNF19A, ZNF787, KIF1B, RPS17, EEF1A1) previously associated with a high replication rate induced more significant, distinct transcriptomic changes than low-replicative variants (RNA18, RPL6), particularly at 168 h. A shared set of 25 genes, especially interferon-stimulated genes (ISGs), was upregulated in cells infected with high-replicating variants. Interestingly, ISG induction was limited at 48 h despite high viral RNA concentrations, suggesting a delayed antiviral response. At 168 h, high ISG expression coincided with high viral loads, indicating that VHRVs may evade or exploit immune defenses. Our findings reveal candidate ISGs such as IFIT1 and ISG15 that may influence HEV persistence and immune escape. These results offer new insights into the interplay between VHRV replication and host immunity. IMPORTANCE Hepatitis E virus (HEV) is a major cause of acute hepatitis and can cause chronic infections in immunocompromised individuals. Virus–host recombinant variants (VHRVs) having integrated host-derived insertions often replicate more effectively, yet the host determinants of this phenotype remain unclear. With RNA sequencing of HepG2/C3A-infected cells, we observed that high-replicating VHRVs induce a delayed but strong expression of interferon-stimulated genes (ISGs), including IFIT1 and ISG15, despite high viral loads. These results suggest that VHRVs may transiently modulate or evade aspects of host antiviral defenses. Our study revealed host transcriptional patterns associated with enhanced viral replication, providing insight into potential mechanisms that enhance HEV replication and highlighting candidate pathways that could influence the interplay between viral replication and immune responses, all requiring further investigation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis E virusVirus ReplicationHepatitis EInterferonsHost-Pathogen InteractionsHumansHep G2 Cells

Stichwörter der Autor:innen

RNA sequencinghepatitis E virusinterferon stimulated genetranscriptomicvirus-host recombinant variants

Substanzen

Interferons

Autor:innen und Institutionen

  • Institut Toulousain des Maladies Infectieuses et Inflammatoires (Infinity), UMR 5051 (CNRS), UMR 1291 (INSERM), Université́ de Toulouse, Toulouse, France.
  • Laboratoire de Virologie, Hôpital Purpan, CHU Toulouse, Toulouse, France.
  • Service des maladies infectieuses et tropicales, Hôpital Purpan, CHU Toulouse, Toulouse, France.
  • I2MC, INSERM UMR 1297, Toulouse, France.
  • GeT-Santé, Plateforme Génome et Transcriptome, GenoToul, Toulouse, France.

ORCID-Profile: Nicolas Jeanne, Nived Collercandy, Jacques Izopet, Sébastien Lhomme

Förderung

  • Agence Nationale de Recherches sur le Sida et les Hépatites Virales (ANRS)

Zitieren

APA

Paronetto, O., Allioux, C., Zahm, M., Gonzalez, A. A., Jeanne, N., Chaubet, A., Collercandy, N., Abravanel, F., Lhuillier, É., Chapuy-Regaud, S., Izopet, J., & Lhomme, S. (2026). Host-interferon-stimulated gene response to virus-host recombinant variants of hepatitis E virus and enhanced viral replication. Microbiology Spectrum. https://doi.org/10.1128/spectrum.00600-26

Vancouver

Paronetto O, Allioux C, Zahm M, Gonzalez AA, Jeanne N, Chaubet A, et al. Host-interferon-stimulated gene response to virus-host recombinant variants of hepatitis E virus and enhanced viral replication. Microbiology Spectrum. 2026. doi:10.1128/spectrum.00600-26

BibTeX
@article{Paronetto2026,
  author = {Paronetto, Olivia and Allioux, Claire and Zahm, Margot and Gonzalez, Anne Alicia and Jeanne, Nicolas and Chaubet, Adeline and Collercandy, Nived and Abravanel, Florence and Lhuillier, Émeline and Chapuy-Regaud, Sabine and Izopet, Jacques and Lhomme, Sébastien},
  title = {Host-interferon-stimulated gene response to virus-host recombinant variants of hepatitis E virus and enhanced viral replication},
  journal = {Microbiology Spectrum},
  year = {2026},
  doi = {10.1128/spectrum.00600-26}
}
Kostenlos starten →